Skip to content

A study of the pattern and percentage distribution of the types of medicines in the OP tickets issued from General Medicine OPD of Palakkad Medical College

Prescription Pattern of Drugs prescribed in the Outpatient Department of General Medicine in a Tertiary Care Center in Palakkad An Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/06/089472
Enrollment
344
Registered
2025-06-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified Health Condition 2: I10- Essential (primary) hypertension Health Condition 3: R69- Illness, unspecified Health Condition 4: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation Health Condition 5: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases attending the General Medicine OPD Patients belonging to any gender Patients above the age of 18 years Patients willing to give written informed consent

Exclusion criteria

Exclusion criteria: Prescriptions containing only non-pharmacological advices Emergency or inpatient prescriptions

Design outcomes

Primary

MeasureTime frame
Average Number of Drugs per EncounterTimepoint: 12 months from the date of approval from Ethics Committee

Secondary

MeasureTime frame
Commonly prescribed drug classes Demographic distribution of patients with respect to age and gender Polypharmacy trends and their clinical relevance Percentage of prescriptions with the occurrence of Adverse Drug Reactions if any recorded from spontaneous patient follow-ups Causality of the ADRs using the WHO UMC scale and NARANJO ADR scale Severity of the ADRs using the modified Hartwig and Siegel scale Pharmacoeconomics of the prescribed drugs with respect to the cost per prescription Timepoint: 12 months from the date of approval from Ethics Committee

Countries

India

Contacts

Public ContactDr ANSHAD YOOSEF K

Government Medical College Palakkad

docsunil2005@gmail.com9645666189

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026